Location: Oslo, Norway
CIK: 0001475373 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 15, 2018
Total Value: $638M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABS | 982,312 | $72.06M | 11.3% | $36.14 | +60.0% | COM | 002824100 |
| BAX | BAXTER INTL INC | 706,228 | $54.44M | 8.5% | $33.52 | +93.7% | COM | 071813109 |
| BSX | BOSTON SCIENTIFIC CORP | 1,383,374 | $53.26M | 8.4% | $15.39 | +127.0% | COM | 101137107 |
| MRK | MERCK & CO INC | 731,046 | $51.86M | 8.1% | $43.18 | +17.3% | COM | 58933Y105 |
| BMY | BRISTOL MYERS SQUIBB CO | 720,880 | $44.75M | 7.0% | $41.27 | +9.0% | COM | 110122108 |
| — | SHIRE PLC | 205,256 | $37.21M | 5.8% | $162.46 | — | SPONSORED ADR | 82481R106 |
| RVTY | PERKINELMER INC | 369,081 | $35.9M | 5.6% | $42.39 | +99.0% | COM | 714046109 |
| BIO | BIO RAD LABS INC | 96,697 | $30.27M | 4.7% | $144.62 | +114.6% | CL A | 090572207 |
| — | NUVASIVE INC | 395,223 | $28.05M | 4.4% | $55.86 | — | COM | 670704105 |
| GILD | GILEAD SCIENCES INC | 323,187 | $24.95M | 3.9% | $53.84 | +5.6% | COM | 375558103 |
| ELV | ANTHEM INC | 83,513 | $22.89M | 3.6% | $128.60 | +83.1% | COM | 036752103 |
| IART | INTEGRA LIFESCIENCES HLDGS C | 338,733 | $22.31M | 3.5% | $35.61 | +74.5% | COM NEW | 457985208 |
| PRGO | PERRIGO CO PLC | 313,220 | $22.18M | 3.5% | $75.60 | -0.7% | SHS | G97822103 |
| A | AGILENT TECHNOLOGIES INC | 213,300 | $15.05M | 2.4% | $62.73 | 0.0% | COM | 00846U101 |
| INCY | INCYTE CORP | 213,764 | $14.77M | 2.3% | $68.64 | 0.0% | COM | 45337C102 |
| UHS | UNIVERSAL HLTH SVCS INC | 105,012 | $13.43M | 2.1% | $114.74 | +3.4% | CL B | 913903100 |
| BIIB | BIOGEN INC | 36,000 | $12.72M | 2.0% | $344.30 | 0.0% | COM | 09062X103 |
| — | PATTERSON COMPANIES INC | 477,707 | $11.68M | 1.8% | $38.09 | — | COM | 703395103 |
| IONS | IONIS PHARMACEUTICALS INC | 202,434 | $10.44M | 1.6% | $50.99 | -7.9% | COM | 462222100 |
| LXRX | LEXICON PHARMACEUTICALS INC | 862,602 | $9.204M | 1.4% | $14.41 | -20.5% | COM NEW | 528872302 |
| CAH | CARDINAL HEALTH INC | 136,335 | $7.362M | 1.2% | $53.21 | -22.7% | COM | 14149Y108 |
| AZN | ASTRAZENECA PLC | 182,905 | $7.238M | 1.1% | $34.02 | — | SPONSORED ADR | 046353108 |
| — | PORTOLA PHARMACEUTICALS INC | 269,701 | $7.182M | 1.1% | $35.34 | — | COM | 737010108 |
| RDY | DR REDDYS LABS LTD | 171,219 | $5.924M | 0.9% | $34.60 | — | ADR | 256135203 |
| — | CLOVIS ONCOLOGY INC | 185,577 | $5.45M | 0.9% | $68.93 | — | COM | 189464100 |
| — | ARRAY BIOPHARMA INC | 334,100 | $5.078M | 0.8% | $15.20 | — | COM | 04269X105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 45,437 | $3.977M | 0.6% | $99.59 | +1.0% | COM | 02043Q107 |
| SGMO | SANGAMO THERAPEUTICS INC | 154,960 | $2.627M | 0.4% | $19.48 | -22.0% | COM | 800677106 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 29,368 | $2.242M | 0.4% | $64.59 | +25.9% | COM | 90400D108 |
| — | SPARK THERAPEUTICS INC | 33,814 | $1.845M | 0.3% | $51.63 | — | COM | 84652J103 |
| LLY | LILLY ELI & CO | 13,650 | $1.465M | 0.2% | $65.37 | +38.1% | COM | 532457108 |